• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » The CenterWatch Monthly, March 2013

The CenterWatch Monthly, March 2013

March 1, 2013
CenterWatch Staff

Sites rate the best sponsors 2013

Anew CenterWatch survey has found sponsors have done a good job maintaining, but not improving, the quality of their relationships with investigative sites during the past two years. Interestingly, as sponsors increasingly adopt integrated and strategic alliances with CROs, sites reported their relationships with sponsors are less effective in several key areas. More than 75% of sites worldwide rated the overall quality of their working relationships with the average sponsor as  “excellent” or “good.” But as sponsors hand over an increasing amount of study conduct to CROs and have less direct contact with sites…

 

As CRO industry turns 30, a look back at modest beginnings

Some of the most well-known CROs—including Chiltern, Quintiles and Parexel—are marking their 30th anniversaries, highlighting the once uncertain road CROs traveled as they evolved from being a market trend to an integral piece of the drug development landscape. In the early 1980s, the drug world was not thinking about outsourcing. The pharmaceutical arena was busy growing in response to the health issues of the decade and conducting groundbreaking research, but was plagued by secrecy, disorganization and a lack of transparency. There were no standard regulations for clinical trials, so doctors wrote each protocol and tried new operating procedures with each trial…

To read the full articles for this issue of The CenterWatch Monthly, please click here for subscription information.

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing